<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39443444</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>23</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>sChemNET: a deep learning framework for predicting small molecules targeting microRNA function.</ArticleTitle><Pagination><StartPage>9149</StartPage><MedlinePgn>9149</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">9149</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-024-49813-w</ELocationID><Abstract><AbstractText>MicroRNAs (miRNAs) have been implicated in human disorders, from cancers to infectious diseases. Targeting miRNAs or their target genes with small molecules offers opportunities to modulate dysregulated cellular processes linked to diseases. Yet, predicting small molecules associated with miRNAs remains challenging due to the small size of small molecule-miRNA datasets. Herein, we develop a generalized deep learning framework, sChemNET, for predicting small molecules affecting miRNA bioactivity based on chemical structure and sequence information. sChemNET overcomes the limitation of sparse chemical information by an objective function that allows the neural network to learn chemical space from a large body of chemical structures yet unknown to affect miRNAs. We experimentally validated small molecules predicted to act on miR-451 or its targets and tested their role in erythrocyte maturation during zebrafish embryogenesis. We also tested small molecules targeting the miR-181 network and other miRNAs using in-vitro and in-vivo experiments. We demonstrate that our machine-learning framework can predict bioactive small molecules targeting miRNAs or their targets in humans and other mammalian organisms.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Galeano</LastName><ForeName>Diego</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-1748-7148</Identifier><AffiliationInfo><Affiliation>Department of Electronics and Mechatronics Engineering, Facultad de Ingeniería, Universidad Nacional de Asunción - FIUNA, Luque, Paraguay. dgaleano@ing.una.py.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>COVID-19 International Research Team, Medford, MA, USA. dgaleano@ing.una.py.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Imrat</LastName><AffiliationInfo><Affiliation>Department of Biochemistry and Cell Biology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haltom</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>COVID-19 International Research Team, Medford, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andolino</LastName><ForeName>Chaylen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Nutrition Science, Purdue University, Indiana, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Purdue Institute for Cancer Research, Purdue University, Indiana, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yousey</LastName><ForeName>Aliza</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>COVID-19 International Research Team, Medford, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Institute, Department of Neurobiology/ Department of Pharmacology and Toxicology, Morehouse School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaksas</LastName><ForeName>Victoria</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-7916-4902</Identifier><AffiliationInfo><Affiliation>COVID-19 International Research Team, Medford, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Translational Data Science, University of Chicago, Chicago, IL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clever Research Lab, Springfield, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Das</LastName><ForeName>Saswati</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>COVID-19 International Research Team, Medford, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Atal Bihari Vajpayee Institute of Medical Sciences and Dr Ram Manohar Lohia Hospital, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baylin</LastName><ForeName>Stephen B</ForeName><Initials>SB</Initials><Identifier Source="ORCID">0000-0003-3697-3798</Identifier><AffiliationInfo><Affiliation>COVID-19 International Research Team, Medford, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sidney Kimmel Comprehensive Cancer Center and Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Van Andel Institute, Grand Rapids, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wallace</LastName><ForeName>Douglas C</ForeName><Initials>DC</Initials><Identifier Source="ORCID">0000-0002-7480-8278</Identifier><AffiliationInfo><Affiliation>COVID-19 International Research Team, Medford, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slack</LastName><ForeName>Frank J</ForeName><Initials>FJ</Initials><Identifier Source="ORCID">0000-0001-8263-0409</Identifier><AffiliationInfo><Affiliation>Harvard Medical School Initiative for RNA Medicine, Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Enguita</LastName><ForeName>Francisco J</ForeName><Initials>FJ</Initials><Identifier Source="ORCID">0000-0002-8072-8557</Identifier><AffiliationInfo><Affiliation>COVID-19 International Research Team, Medford, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wurtele</LastName><ForeName>Eve Syrkin</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Bioinformatics and Computational Biology Program, Department of Genetics, Development, and Cell Biology, Iowa State University, Ames, IA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teegarden</LastName><ForeName>Dorothy</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Nutrition Science, Purdue University, Indiana, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Purdue Institute for Cancer Research, Purdue University, Indiana, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meller</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>COVID-19 International Research Team, Medford, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Institute, Department of Neurobiology/ Department of Pharmacology and Toxicology, Morehouse School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cifuentes</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-5442-4843</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Cell Biology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Virology, Immunology &amp; Microbiology, Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beheshti</LastName><ForeName>Afshin</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4643-531X</Identifier><AffiliationInfo><Affiliation>COVID-19 International Research Team, Medford, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Blue Marble Space Institute of Science, NASA Ames Research Center, Moffett Field, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>McGowan Institute for Regenerative Medicine - Center for Space Biomedicine, Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 CA232589</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 CA232105</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM130935</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA271597</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RM1 HG012334</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C531201">MIRN451 microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054852">Small Molecule Libraries</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015027" MajorTopicYN="Y">Zebrafish</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077321" MajorTopicYN="Y">Deep Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004912" MajorTopicYN="N">Erythrocytes</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054852" MajorTopicYN="N">Small Molecule Libraries</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D047108" MajorTopicYN="N">Embryonic Development</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="N">Neural Networks, Computer</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>D.C.W. is at the Scientific Advisory Boards of Medical Capital Excellence and Pano Therapeutic. Other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>16</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>0</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>23</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39443444</ArticleId><ArticleId IdType="pmc">PMC11500171</ArticleId><ArticleId IdType="doi">10.1038/s41467-024-49813-w</ArticleId><ArticleId IdType="pii">10.1038/s41467-024-49813-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cooper, T. A., Wan, L. &amp; Dreyfuss, G. RNA and disease. Cell136, 777–793 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2866189</ArticleId><ArticleId IdType="pubmed">19239895</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell116, 281–297 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">14744438</ArticleId></ArticleIdList></Reference><Reference><Citation>Esteller, Manel “Non-coding RNAs in human disease.”. Nat. Rev. Genet.12, 861–874 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">22094949</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman, R. C., Farh, K. K.-H., Burge, C. B. &amp; Bartel, D. P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res.19, 92–105 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2612969</ArticleId><ArticleId IdType="pubmed">18955434</ArticleId></ArticleIdList></Reference><Reference><Citation>Iorio, MarilenaV. &amp; Croce, CarloM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol. Med.4, 143–159 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3376845</ArticleId><ArticleId IdType="pubmed">22351564</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurha, P. MicroRNAs in cardiovascular disease. Curr. Opin. Cardiol.31, 249–254 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26885771</ArticleId></ArticleIdList></Reference><Reference><Citation>Rupaimoole, R., Calin, G. A., Lopez-Berestein, G. &amp; Sood, A. K. miRNA deregulation in cancer cells and the tumor microenvironment. Cancer Discov.6, 235–246 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4783232</ArticleId><ArticleId IdType="pubmed">26865249</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald, J. T. et al. Role of miR-2392 in driving SARS-CoV-2 infection. Cell Rep.37, 109839 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8481092</ArticleId><ArticleId IdType="pubmed">34624208</ArticleId></ArticleIdList></Reference><Reference><Citation>Beheshti, A. et al. Identification of circulating serum multi-microRNA signatures in human DLBCL models. Sci. Rep.9, 17161 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6868195</ArticleId><ArticleId IdType="pubmed">31748664</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva, S. S., Lopes, C., Teixeira, A. L., Carneiro de Sousa, M. J. &amp; Medeiros, R. Forensic miRNA: potential biomarker for body fluids? Forensic Sci. Int. Genet.14, 1–10 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25280377</ArticleId></ArticleIdList></Reference><Reference><Citation>Rupaimoole, R. &amp; Slack, F. J. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat. Rev. Drug Discov.16, 203–222 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28209991</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkle, M., El-Daly, S. M., Fabbri, M. &amp; Calin, G. A. Noncoding RNA therapeutics — challenges and potential solutions. Nat. Rev. Drug Discov.20, 629–651 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8212082</ArticleId><ArticleId IdType="pubmed">34145432</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsui, M. &amp; Corey, D. R. Non-coding RNAs as drug targets. Nat. Rev. Drug Discov.16, 167–179 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5831170</ArticleId><ArticleId IdType="pubmed">27444227</ArticleId></ArticleIdList></Reference><Reference><Citation>Agostini, M. &amp; Knight, R. A. miR-34: from bench to bedside. Oncotarget5, 872 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4011589</ArticleId><ArticleId IdType="pubmed">24657911</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakral, S. &amp; Ghoshal, K. miR-122 is a unique molecule with great potential in diagnosis, prognosis of liver disease, and therapy both as miRNA mimic and antimir. Curr. Gene Ther.15, 142–150 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4439190</ArticleId><ArticleId IdType="pubmed">25537773</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhamadani, F. et al. Adverse drug reactions and toxicity of the food and drug administration-approved antisense oligonucleotide drugs. Drug Metab. Dispos.50, 879–887 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11022857</ArticleId><ArticleId IdType="pubmed">35221289</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheridan, C. First small-molecule drug targeting RNA gains momentum. Nat. Biotechnol.39, 6–8 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33432225</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan, R. et al. Small molecules with big roles in microRNA chemical biology and microRNA-targeted therapeutics. RNA Biol.16, 707 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6546413</ArticleId><ArticleId IdType="pubmed">30900502</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, X., Guan, N.-N., Sun, Y.-Z., Li, J.-Q. &amp; Qu, J. MicroRNA-small molecule association identification: from experimental results to computational models. Brief Bioinform.10.1093/bib/bby098 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30325405</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, X. et al. SM2miR: a database of the experimentally validated small molecules’ effects on microRNA expression. Bioinformatics29, 409–411 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23220571</ArticleId></ArticleIdList></Reference><Reference><Citation>Warner, K. D., Hajdin, C. E. &amp; Weeks, K. M. Principles for targeting RNA with drug-like small molecules. Nat. Rev. Drug Discov.17, 547–558 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6420209</ArticleId><ArticleId IdType="pubmed">29977051</ArticleId></ArticleIdList></Reference><Reference><Citation>Costales, M. G., Childs-Disney, J. L., Haniff, H. S. &amp; Disney, M. D. How we think about targeting RNA with small molecules. J. Med. Chem.63, 8880–8900 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7486258</ArticleId><ArticleId IdType="pubmed">32212706</ArticleId></ArticleIdList></Reference><Reference><Citation>Velagapudi, S. P., Gallo, S. M. &amp; Disney, M. D. Sequence-based design of bioactive small molecules that target precursor microRNAs. Nat. Chem. Biol.10, 291–297 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3962094</ArticleId><ArticleId IdType="pubmed">24509821</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan, N.-N., Sun, Y.-Z., Ming, Z., Li, J.-Q. &amp; Chen, X. Prediction of potential small molecule-associated microRNAs using graphlet interaction. Front. Pharmacol.9, 1152 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6196296</ArticleId><ArticleId IdType="pubmed">30374302</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, Xing et al. Predicting potential small molecule–miRNA associations based on bounded nuclear norm regularization. Brief Bioinform.22, bbab328 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34404088</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu, J., Chen, X., Sun, Y.-Z., Li, J.-Q. &amp; Ming, Z. Inferring potential small molecule–miRNA association based on triple layer heterogeneous network. J. Cheminf.10, 30 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6020102</ArticleId><ArticleId IdType="pubmed">29943160</ArticleId></ArticleIdList></Reference><Reference><Citation>Galeano, Diego et al. Predicting the frequencies of drug side effects. Nat. Commun.11, 4575 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7486409</ArticleId><ArticleId IdType="pubmed">32917868</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos, S. de S. et al. Machine learning and network medicine approaches for drug repositioning for COVID-19. Patterns10.1016/j.patter.2021.100396 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8576113</ArticleId><ArticleId IdType="pubmed">34778851</ArticleId></ArticleIdList></Reference><Reference><Citation>Corsello, S. M. et al. The Drug Repurposing Hub: a next-generation drug library and information resource. Nat. Med.23, 405–408 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5568558</ArticleId><ArticleId IdType="pubmed">28388612</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozomara, A., Birgaoanu, M. &amp; Griffiths-Jones, S. miRBase: from microRNA sequences to function. Nucleic Acids Res.47, D155–D162 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6323917</ArticleId><ArticleId IdType="pubmed">30423142</ArticleId></ArticleIdList></Reference><Reference><Citation>Stokes, J. M. et al. A deep learning approach to antibiotic discovery. Cell180, 688–702.e13 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8349178</ArticleId><ArticleId IdType="pubmed">32084340</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang, Juanjuan et al. “RNAInter v4. 0: RNA interactome repository with redefined confidence scoring system and improved accessibility. Nucleic Acids Res.50, D326–D332 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8728132</ArticleId><ArticleId IdType="pubmed">34718726</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludwig, Nicole et al. Distribution of miRNA expression across human tissues. Nucleic Acids Res.44, 3865–3877 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4856985</ArticleId><ArticleId IdType="pubmed">26921406</ArticleId></ArticleIdList></Reference><Reference><Citation>Kretov, D. A., Shafik, A. M. &amp; Cifuentes, D. Assessing miR-451 activity and its role in erythropoiesis. Methods Mol. Biol.1680, 179–190 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29030849</ArticleId></ArticleIdList></Reference><Reference><Citation>Cifuentes, D. et al. A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity. Science328, 1694–1698 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3093307</ArticleId><ArticleId IdType="pubmed">20448148</ArticleId></ArticleIdList></Reference><Reference><Citation>Kretov, D. A. et al. Ago2-dependent processing allows miR-451 to evade the global microRNA turnover elicited during erythropoiesis. Mol. Cell78, 317–328.e6 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7201373</ArticleId><ArticleId IdType="pubmed">32191872</ArticleId></ArticleIdList></Reference><Reference><Citation>Scrimgeour, N. R., Wrobel, A., Pinho, M. J. &amp; Høydal, M. A. microRNA-451a prevents activation of matrix metalloproteinases 2 and 9 in human cardiomyocytes during pathological stress stimulation. Am. J. Physiol. Cell Physiol.318, C94–C102 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31618079</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang, Y. &amp; Li, S. β-elemene suppresses migration of esophageal squamous cell carcinoma by modulating expression of MMP9 through the PI3K/Akt/NF-κB pathway. Comb. Chem. High. Throughput Screen.26, 2304–2320 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36872359</ArticleId></ArticleIdList></Reference><Reference><Citation>Dore, L. C. et al. A GATA-1-regulated microRNA locus essential for erythropoiesis. Proc. Natl Acad. Sci. USA105, 3333–3338 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2265118</ArticleId><ArticleId IdType="pubmed">18303114</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, P. et al. Vitamin D (1,25-(OH)2D3) regulates the gene expression through competing endogenous RNAs networks in high glucose-treated endothelial progenitor cells. J. Steroid Biochem. Mol. Biol.193, 105425 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31302220</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricca, C. et al. Vitamin D receptor is necessary for mitochondrial function and cell health. Int. J. Mol. Sci.19, 1672 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6032156</ArticleId><ArticleId IdType="pubmed">29874855</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarnieri, J. W. et al. Targeted down regulation of core mitochondrial genes during SARS-CoV-2 infection. bioRxiv10.1101/2022.02.19.481089 (2022).</Citation></Reference><Reference><Citation>Ebert, M. S. &amp; Sharp, P. A. Roles for microRNAs in conferring robustness to biological processes. Cell149, 515–524 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3351105</ArticleId><ArticleId IdType="pubmed">22541426</ArticleId></ArticleIdList></Reference><Reference><Citation>Henao-Mejia, J. et al. The microRNA miR-181 is a critical cellular metabolic rheostat essential for NKT cell ontogenesis and lymphocyte development and homeostasis. Immunity38, 984–997 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3738211</ArticleId><ArticleId IdType="pubmed">23623381</ArticleId></ArticleIdList></Reference><Reference><Citation>Indrieri, A., Carrella, S., Carotenuto, P., Banfi, S. &amp; Franco, B. The pervasive role of the miR-181 family in development, neurodegeneration, and cancer. Int. J. Mol. Sci.21, 2092 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7139714</ArticleId><ArticleId IdType="pubmed">32197476</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouyang, Y.-B., Lu, Y., Yue, S. &amp; Giffard, R. G. miR-181 targets multiple Bcl-2 family members and influences apoptosis and mitochondrial function in astrocytes. Mitochondrion12, 213–219 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3250561</ArticleId><ArticleId IdType="pubmed">21958558</ArticleId></ArticleIdList></Reference><Reference><Citation>Indrieri, A. et al. miR‐181a/b downregulation exerts a protective action on mitochondrial disease models. EMBO Mol. Med.11, e8734 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6505685</ArticleId><ArticleId IdType="pubmed">30979712</ArticleId></ArticleIdList></Reference><Reference><Citation>Das, Samarjit et al. Divergent effects of miR‐181 family members on myocardial function through protective cytosolic and detrimental mitochondrial microRNA targets. J. Am. Heart Assoc.6, e004694 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5524005</ArticleId><ArticleId IdType="pubmed">28242633</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji, D. et al. MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1. Mol. Cancer13, 86 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4021214</ArticleId><ArticleId IdType="pubmed">24755295</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, C., Passos Gibson, V. &amp; Hardy, P. The role of MiR-181 family members in endothelial cell dysfunction and tumor angiogenesis. Cells11, 2022 (1670).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9140109</ArticleId><ArticleId IdType="pubmed">35626707</ArticleId></ArticleIdList></Reference><Reference><Citation>Neel, J.-C. &amp; Lebrun, J.-J. Activin and TGFβ regulate expression of the microRNA-181 family to promote cell migration and invasion in breast cancer cells. Cell Signal.25, 1556–1566 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23524334</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai, Z. et al. MiR-181a-5p facilitates proliferation, invasion, and glycolysis of breast cancer through NDRG2-mediated activation of PTEN/AKT pathway. Bioengineered13, 83–95 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8805873</ArticleId><ArticleId IdType="pubmed">34951340</ArticleId></ArticleIdList></Reference><Reference><Citation>Croce, C. M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet.10, 704–714 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3467096</ArticleId><ArticleId IdType="pubmed">19763153</ArticleId></ArticleIdList></Reference><Reference><Citation>Marisetty, A. et al. MiR-181 family modulates osteopontin in glioblastoma multiforme. Cancers12, 3813 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7765845</ArticleId><ArticleId IdType="pubmed">33348707</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh, T. &amp; Adams, B. D. The regulatory role of miRNAs on VDR in breast cancer. Transcription8, 232–241 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5574530</ArticleId><ArticleId IdType="pubmed">28598255</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell, M. J. &amp; Trump, D. L. Vitamin D receptor signaling and cancer. Endocrinol. Metab. Clin. North Am.46, 1009–1038 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092369</ArticleId><ArticleId IdType="pubmed">29080633</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna, J., Hossain, G. S. &amp; Kocerha, J. The potential for microRNA therapeutics and clinical research. Front. Genet. 10, 478 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6532434</ArticleId><ArticleId IdType="pubmed">31156715</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, P. et al. Reprogramming of protein-targeted small-molecule medicines to RNA by ribonuclease recruitment. J. Am. Chem. Soc.143, 13044–13055 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9264281</ArticleId><ArticleId IdType="pubmed">34387474</ArticleId></ArticleIdList></Reference><Reference><Citation>Daina, Antoine, Michielin, Olivier &amp; Zoete, Vincent SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep.7, 42717 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5335600</ArticleId><ArticleId IdType="pubmed">28256516</ArticleId></ArticleIdList></Reference><Reference><Citation>Giangreco, A. A. &amp; Nonn, L. The sum of many small changes: microRNAs are specifically and potentially globally altered by vitamin D3 metabolites. J. Steroid Biochem. Mol. Biol.136, 86–93 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3686905</ArticleId><ArticleId IdType="pubmed">23333596</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez, G. J., Ramírez-Mejía, J. M. &amp; Urcuqui-Inchima, S. Vitamin D boosts immune response of macrophages through a regulatory network of microRNAs and mRNAs. J. Nutr. Biochem.109, 109105 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35858666</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Z., Moon, R., Thorne, J. L. &amp; Moore, J. B. NAFLD and vitamin D: evidence for intersection of microRNA-regulated pathways. Nutr. Res. Rev.36, 120–139 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">35109946</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan, Z. C. et al. 1α,25-Dihydroxyvitamin D3 regulates mitochondrial oxygen consumption and dynamics in human skeletal muscle cells. J. Biol. Chem.291, 1514–1528 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4714233</ArticleId><ArticleId IdType="pubmed">26601949</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma, X. et al. microRNA-501-5p promotes cell proliferation and migration in gastric cancer by downregulating LPAR1. J. Cell. Biochem.121, 1911–1922 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31746031</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Z., Shao, L., Wang, Y. &amp; Luo, X. MicroRNA-501-3p restricts prostate cancer growth through regulating cell cycle-related and expression-elevated protein in tumor/cyclin D1 signaling. Biochem. Biophys. Res. Commun.509, 746–752 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30621914</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao, Yueguang et al. MicroRNA-501-5p targets PINX1 gene to regulate the proliferation, migration, and invasion of prostatic carcinoma cells. J. Biomater. Tissue Eng.11, 471–477 (2021).</Citation></Reference><Reference><Citation>Cereto-Massagué, A. et al. Molecular fingerprint similarity search in virtual screening. Methods71, 58–63 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25132639</ArticleId></ArticleIdList></Reference><Reference><Citation>Landrum, G. RDKit: A Software Suite for Cheminformatics, Computational Chemistry, and Predictive Modeling (Academic Press, 2013).</Citation></Reference><Reference><Citation>Jiang, L., Ding, Y., Tang, J. &amp; Guo, F. MDA-SKF: similarity kernel fusion for accurately discovering miRNA-disease association. Front. Genet.9, 618 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6295467</ArticleId><ArticleId IdType="pubmed">30619454</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, L. et al. SCMFMDA: predicting microRNA-disease associations based on similarity constrained matrix factorization. PLoS Comput. Biol.17, e1009165 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8345837</ArticleId><ArticleId IdType="pubmed">34252084</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheeley, M. P. et al. 1α,25-dihydroxyvitamin D reduction of MCF10A-ras cell viability in extracellular matrix detached conditions is dependent on regulation of pyruvate carboxylase. J. Nutr. Biochem.109, 109116 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9719603</ArticleId><ArticleId IdType="pubmed">35934270</ArticleId></ArticleIdList></Reference><Reference><Citation>Zembroski, AlyssaS. et al. Proteomic characterization of cytoplasmic lipid droplets in human metastatic breast cancer cells. Front. Oncol.11, 576326 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8204105</ArticleId><ArticleId IdType="pubmed">34141606</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh, U., Li, J., Seetharam, A. &amp; Wurtele, E. S. pyrpipe: a Python package for RNA-Seq workflows. NAR Genom. Bioinform.3, lqab049 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8168212</ArticleId><ArticleId IdType="pubmed">34085037</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedländer, MarcR. et al. miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades. Nucleic Acids Res.40, 37–52 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3245920</ArticleId><ArticleId IdType="pubmed">21911355</ArticleId></ArticleIdList></Reference><Reference><Citation>Love, M. I., Huber, W. &amp; Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol.15, 550 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>